Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.800
-0.060 (-3.23%)
Nov 4, 2024, 4:00 PM EST - Market closed

BCLI Statistics

Total Valuation

BCLI has a market cap or net worth of $9.57 million. The enterprise value is $7.38 million.

Market Cap 9.57M
Enterprise Value 7.38M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, before market open.

Earnings Date Nov 15, 2024
Ex-Dividend Date n/a

Share Statistics

BCLI has 5.32 million shares outstanding. The number of shares has increased by 54.99% in one year.

Shares Outstanding 5.32M
Shares Change (YoY) +54.99%
Shares Change (QoQ) +10.00%
Owned by Insiders (%) 7.21%
Owned by Institutions (%) 5.35%
Float 4.27M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.50

Current Ratio 0.50
Quick Ratio 0.46
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -36.45

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -178.20%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$439,517
Employee Count 29
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -29.82% in the last 52 weeks. The beta is 0.39, so BCLI's price volatility has been lower than the market average.

Beta (5Y) 0.39
52-Week Price Change -29.82%
50-Day Moving Average 3.11
200-Day Moving Average 5.52
Relative Strength Index (RSI) 29.08
Average Volume (20 Days) 83,503

Short Selling Information

The latest short interest is 165,892, so 3.12% of the outstanding shares have been sold short.

Short Interest 165,892
Short Previous Month 1.87M
Short % of Shares Out 3.12%
Short % of Float 3.88%
Short Ratio (days to cover) 2.85

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -16.30M
Pretax Income -15.53M
Net Income -12.75M
EBITDA -16.04M
EBIT -16.30M
Earnings Per Share (EPS) -$3.31
Full Income Statement

Balance Sheet

The company has $3.47 million in cash and $962,000 in debt, giving a net cash position of $2.51 million or $0.47 per share.

Cash & Cash Equivalents 3.47M
Total Debt 962,000
Net Cash 2.51M
Net Cash Per Share $0.47
Equity (Book Value) -3.53M
Book Value Per Share -0.66
Working Capital -3.88M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.44 million and capital expenditures -$18,000, giving a free cash flow of -$14.46 million.

Operating Cash Flow -14.44M
Capital Expenditures -18,000
Free Cash Flow -14.46M
FCF Per Share -$2.72
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BCLI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -54.99%
Shareholder Yield -54.99%
Earnings Yield -128.92%
FCF Yield -146.23%

Analyst Forecast

The average price target for BCLI is $30.00, which is 1,566.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target $30.00
Price Target Difference 1,566.67%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on October 1, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date Oct 1, 2024
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1